NewslettersCell Therapy NewsCardiac and Inflammatory Biomarker Differences in Adverse Cardiac Events after Chimeric Antigen Receptor T-Cell Therapy: An Exploratory StudyBy Jamie Kang - April 3, 20230129Researchers investigated the changes in cardiac and inflammatory biomarkers in CAR-T therapy to determine the role of pro-inflammatory cytokines.[Cardio-Oncology]Full Article